Genome Editing/Genome Engineering Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Size, Share & Trends, Drivers, Restraints, Opportunities, Manufacturer, Applications, And Segments

  • AMR-1067418
  • December 2021
  • Healthcare
  • 125 Pages
Report Description

This report is a comprehensive study that examines the Genome Editing/Genome Engineering industry in depth. With reference to key regions and major nations, the study specifies the product type of Genome Editing/Genome Engineering as well as its use in various industrial verticals. Furthermore, the report identified and analysed all of the top companies functioning in the global Genome Editing/Genome Engineering market arena, comparing and contrasting them based on market revenue, yearly sales volume, historical growth rate, and company strategies. The worldwide Genome Editing/Genome Engineering market research offers a business strategy for current market participants to strengthen their market positions based on all of these findings. Furthermore, the paper recommends a market entry strategy for newcomers to the sector.

The top vendors and distributors operating in all of the major regions have also been highlighted in the Genome Editing/Genome Engineering market report. This data and research should aid market players in strengthening their market distribution networks and expanding their geographic reach.
 
Genome Editing/Genome Engineering Market Strategic Analysis 

The market was studied using several marketing methodologies such as Porter's Five Forces Analysis, player positioning analysis, SWOT analysis, market share analysis, and value chain analysis in the Genome Editing/Genome Engineering market study. The market dynamics and factors such as the threat of a Genome Editing/Genome Engineering substitute, the threat of new entrants into the Genome Editing/Genome Engineering market, buyer bargaining power, supplier bargaining power to Genome Editing/Genome Engineering providing companies, and internal rivalry among Genome Editing/Genome Engineering providers are analysed in Porter's Five Forces analysis to provide the report's readers with a detailed view of the current market dynamics.

This analysis assists report users in evaluating the Genome Editing/Genome Engineering market based on various parameters such as economies of scale, switching costs, brand loyalty, existing distribution channels, capital investments, manufacturing rights & patents, government regulations, advertising impact, and consumer preference impact. This simplified data is expected to aid the industry's key decision-makers in their decision-making process. Furthermore, this study answers the crucial question of whether or not new entrants should enter the Genome Editing/Genome Engineering industry.
 
Genome Editing/Genome Engineering Market Key Trends Analysis

The important factors influencing the growth of the Genome Editing/Genome Engineering market have been examined in this report. The driving factors that are boosting demand for Genome Editing/Genome Engineerings and the restraining factors that are slowing growth of the Genome Editing/Genome Engineering industry are addressed in depth, as well as their implications for the worldwide Genome Editing/Genome Engineering market. In addition, the published analysis identifies and discusses in detail the trends that are driving the market and impacting its growth. In addition, other qualitative variables such as risks connected with operations and key problems faced by market players are covered in the report.

Genome Editing/Genome Engineering Market Key Segment Analysis

By segmenting the market by product type, application, and geography, the study provides a clear picture of the Genome Editing/Genome Engineering industry. On the basis of current and future trends, all segments of the Genome Editing/Genome Engineering industry have been examined. The market and its divisions are forecasted for the years 2021 through 2028. The study identifies the categories that are contributing the most to total market revenue growth, as well as the factors that are supporting their growth.

The research will provide a detailed qualitative and quantitative product type segment analysis for the years 2021 to 2028.

The report study analyses and includes a variety of prospective prospects and aspects affecting various applications.
 
Genome Editing/Genome Engineering Market Regional Trends and Market Player’s Analysis

North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa are the regions in which the market is divided. In 2020, the worldwide Genome Editing/Genome Engineering market was dominated by North America. The Asia Pacific region is expected to have the highest CAGR for the Genome Editing/Genome Engineering market throughout the projected period.


 
The market revenue, market shares, business strategies, recent developments, and growth rates of major players with substantial market shares in the global Genome Editing/Genome Engineering market are all examined. These firms' recent developments, such as new solution/product launches, research projects, acquisitions, geographic expansions, and technological advancements, are taken into account when determining their position in the Genome Editing/Genome Engineering market. All important stakeholders in the Genome Editing/Genome Engineering value chain and technological ecosystem are expected to benefit from the insights offered in the Genome Editing/Genome Engineering market research study.

In order to provide a broader understanding of the top competitors in the Genome Editing/Genome Engineering market, the research includes a company market share analysis. Agilent Technologies, Beam Therapeutics, Bluebird Bio Inc., Caribou Biosciences, Cellectis S.A, Creative Biogene, Crispr Therapeutics Ag, Editas Medicine, Genscript, Integrated Dna Technologies, Intellia Therapeutics, Lonza, Merck Kgaa, New England Biolabs, Origene Technologies, Perkinelmer, Precision Biosciences, Recombinetics, Regeneron Pharmaceuticals Inc., Sangamo Therapeutics, Synthego Corporation, Tecan Life Sciences, Thermo Fisher Scientific, Transposagen Biopharmaceuticals [Hera Biolabs], Vigene Biosciences are among the major participants in the global Genome Editing/Genome Engineering industry.
 
Scope of the report
Report Parameters Details of Parameter
Market Size xx Million
Based Year 2021
Forecast Period Covered 2021-2028
Units for value Revenue in USD million and CAGR from 2021 to 2028
Covered Segments Component, Types, Applications, End-Users, and more.
Region Covered North America, Europe, Asia Pacific, Latin America, Middle East and Africa
Companies Covered Agilent Technologies, Beam Therapeutics, Bluebird Bio Inc., Caribou Biosciences, Cellectis S.A, Creative Biogene, Crispr Therapeutics Ag, Editas Medicine, Genscript, Integrated Dna Technologies, Intellia Therapeutics, Lonza, Merck Kgaa, New England Biolabs, Origene Technologies, Perkinelmer, Precision Biosciences, Recombinetics, Regeneron Pharmaceuticals Inc., Sangamo Therapeutics, Synthego Corporation, Tecan Life Sciences, Thermo Fisher Scientific, Transposagen Biopharmaceuticals [Hera Biolabs], Vigene Biosciences
 
Major Highlights of the Genome Editing/Genome Engineering Market report study:
  • An in-depth examination of the global Genome Editing/Genome Engineering industry will be published soon.
  • The study examines the global Genome Editing/Genome Engineering market and offers major actionable information to its players.
  • The research has taken into account all key events in the recent past, providing users with up-to-date industry information.
  • The report study is expected to aid the industry's key decision-makers in their decision-making process.
  • Data on market intelligence, changing market dynamics, existing and predicted market trends, and so on are included in the report.
  • The research includes a detailed examination of the macroeconomic and microeconomic aspects that influence the global Genome Editing/Genome Engineering industry.
  • The Market Ecosystem and Adoption in Different Markets
  • The global Genome Editing/Genome Engineering market is being shaped by several major trends.
  • The size of the Genome Editing/Genome Engineering market in terms of revenue has been measured in the past and will be measured in the future in USD million.
  • Consumer preference patterns and recent industrial developments
  • The worldwide Genome Editing/Genome Engineering market's competitive landscape and player positioning analysis
  • Major players' key goods and solutions, as well as their business strategies
  • Recommendations for new market entrants as well as existing market participants.
  • The study of niche and potential segments (product type, application, and regions/countries) predicts that promising growth will be noticed.
  • Operating players in the market encounter a number of significant hurdles.
  • An examination of the major risks involved in market operations
 
The report segment of the global Genome Editing/Genome Engineering market as follows:
Global Genome Editing/Genome Engineering Market: By Product Type

  • CRISPR
  • TALEN
  • ZFN
  • Antisense

Global Genome Editing/Genome Engineering Market: By Application
  • Cell Line Engineering
  • Genetic Engineering
  • Diagnostics

Global Genome Editing/Genome Engineering Market: By Region
  • North America
    • U.S.
    • Canada
    • Rest of North America
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China 
    • Japan
    • India
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Argentina
    • Rest of Latin America
  • Middle East and Africa
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

The report study is drafted to provide actionable insights to the following mentioned audience:
  • Institutes of research and consulting firms
  • Companies are attempting to get into the Genome Editing/Genome Engineering market.
  • Universities and students
  • Other companies in the Genome Editing/Genome Engineering market include solution providers, product producers, service providers, and others.
  • Private companies and government agencies that are linked
  • Individuals interested in learning more about the Genome Editing/Genome Engineering market

Manufacturers and Segments

  • Agilent Technologies
  • Beam Therapeutics
  • Bluebird Bio Inc.
  • Caribou Biosciences
  • Cellectis S.A
  • Creative Biogene
  • Crispr Therapeutics Ag
  • Editas Medicine
  • Genscript
  • Integrated Dna Technologies
  • Intellia Therapeutics
  • Lonza
  • Merck Kgaa
  • New England Biolabs
  • Origene Technologies
  • Perkinelmer
  • Precision Biosciences
  • Recombinetics
  • Regeneron Pharmaceuticals Inc.
  • Sangamo Therapeutics
  • Synthego Corporation
  • Tecan Life Sciences
  • Thermo Fisher Scientific
  • Transposagen Biopharmaceuticals [Hera Biolabs]
  • Vigene Biosciences
  • CRISPR
  • TALEN
  • ZFN
  • Antisense
  • Cell Line Engineering
  • Genetic Engineering
  • Diagnostics

Have query on this report?

Make an Enquiry
1. Preface
     1.1. Report Scope and Description
     1.2. Research Methodology
          1.2.1. Phase I-Secondary Research
          1.2.2. Phase II-Primary Research
          1.2.3. Phase II-Expert Panel Review
          1.2.4. Assumptions
          1.2.5. Approach Adopted

2. Executive Summarysegment Form
     2.1. Global Genome Editing/Genome Engineering Market Snapshot
          2.1.1. Global Genome Editing/Genome Engineering Market By CRISPR,2019
               2.1.1.1.
               2.1.1.2.CRISPR
               2.1.1.3.TALEN
               2.1.1.4.ZFN
          2.1.2. Global Genome Editing/Genome Engineering Market By Cell Line Engineering,2019
               2.1.2.1.
               2.1.2.2.Cell Line Engineering
               2.1.2.3.Genetic Engineering
          2.1.3. Global Genome Editing/Genome Engineering Market By End-use,2019
          2.1.4. Global Genome Editing/Genome Engineering Market By Geography,2019

3. Global Genome Editing/Genome Engineering Market Dynamics
     3.1. Market Overview
     3.2. Market Inclination Insights Analysis
     3.3. Drivers
     3.4. Challenges
     3.5. Future Prospects
     3.6. Impact Analysis of Drivers and Challenges During the Forecast Period, (2020-2028)

4. Global Genome Editing/Genome Engineering Market Size (US$), By CRISPR, 2018 – 2028 
     4.1. Overview
          4.1.1. Market Share Analysis By CRISPR, 2019 vs.2028
          4.1.2. Attractive Investment Proposition By CRISPR, 2020
     4.2. Global Genome Editing/Genome Engineering Market Size (US$), By CRISPR, 2018 – 2028

5. Global Genome Editing/Genome Engineering Market Size (US$), By Cell Line Engineering, 2018 – 2028 
     5.1. Overview
          5.1.1. Market Share Analysis By Cell Line Engineering, 2019 vs.2028
          5.1.2. Attractive Investment Proposition By Cell Line Engineering, 2020
     5.2. Global Genome Editing/Genome Engineering Market Size (US$), By Cell Line Engineering, 2018 – 2028

6. Global Genome Editing/Genome Engineering Market Size (US$), By End-use, 2018 – 2028 
     6.1. Overview
          6.1.1. Market Share Analysis By End-use, 2019 vs.2028
          6.1.2. Attractive Investment Proposition By End-use, 2020
     6.2. Global Genome Editing/Genome Engineering Market Size (US$), By End-use, 2018 – 2028

7. Global Genome Editing/Genome Engineering Market Size (US$), By Geography, 2018 – 2028
     7.1. Overview
          7.1.1. Market Share Analysis by Geography, 2019 vs. 2028
          7.1.2. Attractive Investment Proposition by Geography, 2020
     7.2. North America Genome Editing/Genome Engineering Market Analysis, 2018 – 2028 
          7.2.1. North America Genome Editing/Genome Engineering Market Size (US$), By Country, 2018 – 2028 
               7.2.1.1. U.S.
               7.2.1.2. Canada
          7.2.2. North America Genome Editing/Genome Engineering Market Size (US$), By CRISPR, 2018 – 2028
          7.2.3. North America Genome Editing/Genome Engineering Market Size (US$), By Cell Line Engineering, 2018 – 2028
          7.2.4. North America Genome Editing/Genome Engineering Market Size (US$), By End-use, 2018 – 2028
     7.3. Europe Genome Editing/Genome Engineering Market Analysis, 2018 – 2028 
          7.3.1.  Europe Genome Editing/Genome Engineering Market Size (US$), By Country, 2018 – 2028 
               7.3.1.1. U.K.
               7.3.1.2. Germany
               7.3.1.3. France
               7.3.1.4. Rest of Europe
          7.3.2. Europe Genome Editing/Genome Engineering Market Size (US$), By CRISPR, 2018 – 2028
          7.3.3. Europe Genome Editing/Genome Engineering Market Size (US$), By Cell Line Engineering, 2018 – 2028
          7.3.4. Europe Genome Editing/Genome Engineering Market Size (US$), By End-use, 2018 – 2028
     7.4. Asia Pacific Genome Editing/Genome Engineering Market Analysis , 2018 – 2028
          7.4.1.  Asia Pacific Genome Editing/Genome Engineering Market Size (US$), By Country, 2018 – 2028 
               7.4.1.1. China
               7.4.1.2. Japan
               7.4.1.3. India
               7.4.1.4. Rest of Asia Pacific
          7.4.2. Asia Pacific Genome Editing/Genome Engineering Market Size (US$), By CRISPR, 2018 – 2028
          7.4.3. Asia Pacific Genome Editing/Genome Engineering Market Size (US$), By Cell Line Engineering, 2018 – 2028
          7.4.4. Asia Pacific Genome Editing/Genome Engineering Market Size (US$), By End-use, 2018 – 2028
     7.5. Latin America Genome Editing/Genome Engineering Market Analysis, 2018 – 2028 
          7.5.1.  Latin America Genome Editing/Genome Engineering Market Size (US$), By Country, 2018 – 2028 
               7.5.1.1. Brazil
               7.5.1.2. Mexico
               7.5.1.3. Rest of Latin America
          7.5.2. Latin America Genome Editing/Genome Engineering Market Size (US$), By CRISPR, 2018 – 2028
          7.5.3. Latin America Genome Editing/Genome Engineering Market Size (US$), By Cell Line Engineering, 2018 – 2028
          7.5.4. Latin America Genome Editing/Genome Engineering Market Size (US$), By End-use, 2018 – 2028
     7.6. Middle East & Africa (MEA) Genome Editing/Genome Engineering Market Analysis, 2018 – 2028 
          7.6.1.  MEA Genome Editing/Genome Engineering Market Size (US$), By Region, 2018 – 2028 
               7.6.1.1. GCC Countries
               7.6.1.2. South Africa
               7.6.1.3. Rest of MEA
          7.6.2. MEA Genome Editing/Genome Engineering Market Size (US$), By CRISPR, 2018 – 2028
          7.6.3. MEA Genome Editing/Genome Engineering Market Size (US$), By Cell Line Engineering, 2018 – 2028
          7.6.4. MEA Genome Editing/Genome Engineering Market Size (US$), By End-use, 2018 – 2028

8. Company Profiles
     8.1. Competitive Analysis 
     8.2. Market Positioning of Key Vendors 
     8.3. Key Strategies adopted by the Leading Players
     8.4. Key Genome Editing/Genome Engineering Providers
        8.4.1 Agilent Technologies
                8.4.1.1 Business Description
                8.4.1.2 Agilent Technologies Geographic Operations
                8.4.1.3 Agilent Technologies Financial Information
                8.4.1.4 Agilent Technologies Product Positions/Portfolio
                8.4.1.5 Agilent Technologies Key Developments
        8.4.2 Beam Therapeutics
                8.4.2.1 Business Description
                8.4.2.2 Beam Therapeutics Geographic Operations
                8.4.2.3 Beam Therapeutics Financial Information
                8.4.2.4 Beam Therapeutics Product Positions/Portfolio
                8.4.2.5 Beam Therapeutics Key Developments
        8.4.3 Bluebird Bio Inc.
                8.4.3.1 Business Description
                8.4.3.2 Bluebird Bio Inc. Geographic Operations
                8.4.3.3 Bluebird Bio Inc. Financial Information
                8.4.3.4 Bluebird Bio Inc. Product Positions/Portfolio
                8.4.3.5 Bluebird Bio Inc. Key Developments
        8.4.4 Caribou Biosciences
                8.4.4.1 Business Description
                8.4.4.2 Caribou Biosciences Geographic Operations
                8.4.4.3 Caribou Biosciences Financial Information
                8.4.4.4 Caribou Biosciences Product Positions/Portfolio
                8.4.4.5 Caribou Biosciences Key Developments
        8.4.5 Cellectis S.A
                8.4.5.1 Business Description
                8.4.5.2 Cellectis S.A Geographic Operations
                8.4.5.3 Cellectis S.A Financial Information
                8.4.5.4 Cellectis S.A Product Positions/Portfolio
                8.4.5.5 Cellectis S.A Key Developments
        8.4.6 Creative Biogene
                8.4.6.1 Business Description
                8.4.6.2 Creative Biogene Geographic Operations
                8.4.6.3 Creative Biogene Financial Information
                8.4.6.4 Creative Biogene Product Positions/Portfolio
                8.4.6.5 Creative Biogene Key Developments
        8.4.7 Crispr Therapeutics Ag
                8.4.7.1 Business Description
                8.4.7.2 Crispr Therapeutics Ag Geographic Operations
                8.4.7.3 Crispr Therapeutics Ag Financial Information
                8.4.7.4 Crispr Therapeutics Ag Product Positions/Portfolio
                8.4.7.5 Crispr Therapeutics Ag Key Developments
        8.4.8 Editas Medicine
                8.4.8.1 Business Description
                8.4.8.2 Editas Medicine Geographic Operations
                8.4.8.3 Editas Medicine Financial Information
                8.4.8.4 Editas Medicine Product Positions/Portfolio
                8.4.8.5 Editas Medicine Key Developments
        8.4.9 Genscript
                8.4.9.1 Business Description
                8.4.9.2 Genscript Geographic Operations
                8.4.9.3 Genscript Financial Information
                8.4.9.4 Genscript Product Positions/Portfolio
                8.4.9.5 Genscript Key Developments
        8.4.10 Integrated Dna Technologies
                8.4.10.1 Business Description
                8.4.10.2 Integrated Dna Technologies Geographic Operations
                8.4.10.3 Integrated Dna Technologies Financial Information
                8.4.10.4 Integrated Dna Technologies Product Positions/Portfolio
                8.4.10.5 Integrated Dna Technologies Key Developments
        8.4.11 Intellia Therapeutics
                8.4.11.1 Business Description
                8.4.11.2 Intellia Therapeutics Geographic Operations
                8.4.11.3 Intellia Therapeutics Financial Information
                8.4.11.4 Intellia Therapeutics Product Positions/Portfolio
                8.4.11.5 Intellia Therapeutics Key Developments
        8.4.12 Lonza
                8.4.12.1 Business Description
                8.4.12.2 Lonza Geographic Operations
                8.4.12.3 Lonza Financial Information
                8.4.12.4 Lonza Product Positions/Portfolio
                8.4.12.5 Lonza Key Developments
        8.4.13 Merck Kgaa
                8.4.13.1 Business Description
                8.4.13.2 Merck Kgaa Geographic Operations
                8.4.13.3 Merck Kgaa Financial Information
                8.4.13.4 Merck Kgaa Product Positions/Portfolio
                8.4.13.5 Merck Kgaa Key Developments
        8.4.14 New England Biolabs
                8.4.14.1 Business Description
                8.4.14.2 New England Biolabs Geographic Operations
                8.4.14.3 New England Biolabs Financial Information
                8.4.14.4 New England Biolabs Product Positions/Portfolio
                8.4.14.5 New England Biolabs Key Developments
        8.4.15 Origene Technologies
                8.4.15.1 Business Description
                8.4.15.2 Origene Technologies Geographic Operations
                8.4.15.3 Origene Technologies Financial Information
                8.4.15.4 Origene Technologies Product Positions/Portfolio
                8.4.15.5 Origene Technologies Key Developments
        8.4.16 Perkinelmer
                8.4.16.1 Business Description
                8.4.16.2 Perkinelmer Geographic Operations
                8.4.16.3 Perkinelmer Financial Information
                8.4.16.4 Perkinelmer Product Positions/Portfolio
                8.4.16.5 Perkinelmer Key Developments
        8.4.17 Precision Biosciences
                8.4.17.1 Business Description
                8.4.17.2 Precision Biosciences Geographic Operations
                8.4.17.3 Precision Biosciences Financial Information
                8.4.17.4 Precision Biosciences Product Positions/Portfolio
                8.4.17.5 Precision Biosciences Key Developments
        8.4.18 Recombinetics
                8.4.18.1 Business Description
                8.4.18.2 Recombinetics Geographic Operations
                8.4.18.3 Recombinetics Financial Information
                8.4.18.4 Recombinetics Product Positions/Portfolio
                8.4.18.5 Recombinetics Key Developments
        8.4.19 Regeneron Pharmaceuticals Inc.
                8.4.19.1 Business Description
                8.4.19.2 Regeneron Pharmaceuticals Inc. Geographic Operations
                8.4.19.3 Regeneron Pharmaceuticals Inc. Financial Information
                8.4.19.4 Regeneron Pharmaceuticals Inc. Product Positions/Portfolio
                8.4.19.5 Regeneron Pharmaceuticals Inc. Key Developments
        8.4.20 Sangamo Therapeutics
                8.4.20.1 Business Description
                8.4.20.2 Sangamo Therapeutics Geographic Operations
                8.4.20.3 Sangamo Therapeutics Financial Information
                8.4.20.4 Sangamo Therapeutics Product Positions/Portfolio
                8.4.20.5 Sangamo Therapeutics Key Developments
        8.4.21 Synthego Corporation
                8.4.21.1 Business Description
                8.4.21.2 Synthego Corporation Geographic Operations
                8.4.21.3 Synthego Corporation Financial Information
                8.4.21.4 Synthego Corporation Product Positions/Portfolio
                8.4.21.5 Synthego Corporation Key Developments
        8.4.22 Tecan Life Sciences
                8.4.22.1 Business Description
                8.4.22.2 Tecan Life Sciences Geographic Operations
                8.4.22.3 Tecan Life Sciences Financial Information
                8.4.22.4 Tecan Life Sciences Product Positions/Portfolio
                8.4.22.5 Tecan Life Sciences Key Developments
        8.4.23 Thermo Fisher Scientific
                8.4.23.1 Business Description
                8.4.23.2 Thermo Fisher Scientific Geographic Operations
                8.4.23.3 Thermo Fisher Scientific Financial Information
                8.4.23.4 Thermo Fisher Scientific Product Positions/Portfolio
                8.4.23.5 Thermo Fisher Scientific Key Developments
        8.4.24 Transposagen Biopharmaceuticals [Hera Biolabs]
                8.4.24.1 Business Description
                8.4.24.2 Transposagen Biopharmaceuticals [Hera Biolabs] Geographic Operations
                8.4.24.3 Transposagen Biopharmaceuticals [Hera Biolabs] Financial Information
                8.4.24.4 Transposagen Biopharmaceuticals [Hera Biolabs] Product Positions/Portfolio
                8.4.24.5 Transposagen Biopharmaceuticals [Hera Biolabs] Key Developments
        8.4.25 Vigene Biosciences
                8.4.25.1 Business Description
                8.4.25.2 Vigene Biosciences Geographic Operations
                8.4.25.3 Vigene Biosciences Financial Information
                8.4.25.4 Vigene Biosciences Product Positions/Portfolio
                8.4.25.5 Vigene Biosciences Key Developments

LIST OF TABLES

TABLE 1 Market Snapshot: Global Genome Editing/Genome Engineering Market 
TABLE 2 Impact Indicators 
TABLE 3 Impact Analysis of Drivers and Restraints 
TABLE 4 North America Genome Editing/Genome Engineering Market Revenue, By CRISPR, 2018 – 2028 (US$ Mn) 
TABLE 5 North America Genome Editing/Genome Engineering Market Revenue, By Cell Line Engineering, 2018 – 2028 (US$ Mn) 
TABLE 6 North America Genome Editing/Genome Engineering Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 7 Europe Genome Editing/Genome Engineering Market Revenue, By CRISPR, 2018 – 2028 (US$ Mn) 
TABLE 8 Europe Genome Editing/Genome Engineering Market Revenue, By Cell Line Engineering, 2018 – 2028 (US$ Mn) 
TABLE 9 Europe Genome Editing/Genome Engineering Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 10 Asia Pacific Genome Editing/Genome Engineering Market Revenue, By CRISPR, 2018 – 2028 (US$ Mn) 
TABLE 11 Asia Pacific Genome Editing/Genome Engineering Market Revenue, By Cell Line Engineering, 2018 – 2028 (US$ Mn) 
TABLE 12 Asia Pacific Genome Editing/Genome Engineering Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 13 Latin America Genome Editing/Genome Engineering Market Revenue, By CRISPR, 2018 – 2028 (US$ Mn) 
TABLE 14 Latin America Genome Editing/Genome Engineering Market Revenue, By Cell Line Engineering, 2018 – 2028 (US$ Mn) 
TABLE 15 Latin America Genome Editing/Genome Engineering Market Revenue, By End-use, 2018 – 2028 (US$ Mn)
TABLE 16 MEA Genome Editing/Genome Engineering Market Revenue, By CRISPR, 2018 – 2028 (US$ Mn) 
TABLE 17 MEA Genome Editing/Genome Engineering Market Revenue, By Cell Line Engineering, 2018 – 2028 (US$ Mn) 
TABLE 18 MEA Genome Editing/Genome Engineering Market Revenue, By End-use, 2018 – 2028 (US$ Mn)

LIST OF FIGURES

FIG. 1 Global Genome Editing/Genome Engineering: Market Segmentation 
FIG. 2 Global Genome Editing/Genome Engineering Market: Research Methodology 
FIG. 3 Top-Down and Bottom-up Approach 
FIG. 4 Global Genome Editing/Genome Engineering Market, By CRISPR, 2019 (US$ Mn) 
FIG. 5 Global Genome Editing/Genome Engineering Market, By Cell Line Engineering, 2019 (US$ Mn) 
FIG. 6 Global Genome Editing/Genome Engineering Market, By End-use, 2019 (US$ Mn) 
FIG. 7 Global Genome Editing/Genome Engineering Market, By Geography, 2019 (US$ Mn) 
FIG. 8 Global Genome Editing/Genome Engineering Market Revenue and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG. 9 Attractive Investment Proposition 
FIG. 10 Market Positioning of Key Genome Editing/Genome Engineering Providers, 2019
FIG. 11 Global Genome Editing/Genome Engineering Market Revenue Contribution, By CRISPR, 2019 & 2028 (Value %) 
FIG. 12 Global Genome Editing/Genome Engineering Market Revenue Contribution, By Cell Line Engineering, 2019 & 2028 (Value %) 
FIG. 13 Global Genome Editing/Genome Engineering Market Revenue Contribution, By End-use, 2019 & 2028 (Value %) 
FIG. 14 North America Genome Editing/Genome Engineering Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 15 Europe Genome Editing/Genome Engineering Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 16 Asia Pacific Genome Editing/Genome Engineering Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 17 Latin America Genome Editing/Genome Engineering Market Revenue, 2018 – 2028, (US$ Mn)
FIG. 18 MEA Genome Editing/Genome Engineering Market Revenue, 2018 – 2028, (US$ Mn)

Key Takeaways:

1. Market value and estimate of the Genome Editing/Genome Engineering market for the period from 2020 to 2028
2. Compounded annual growth rate (CAGR%) for individual segments in various regional markets for a period from 2020 to 2028
3. Value chain analysis
4. Market share study combined with competitive landscape of major players
5. Profiles of major market players covering overall business operations, geographic occurrence, product portfolio, financial status and news coverage 

List of Tables

TABLE  Market Snapshot: Global Genome Editing/Genome Engineering Market
TABLE  Impact Pointers
TABLE  Impact Analysis of Drivers and Restraints
TABLE  North America Genome Editing/Genome Engineering Market Value, By Segment1, 2018 – 2028
TABLE  North America Genome Editing/Genome Engineering Market Value, By Segment2, 2018 – 2028
TABLE  North America Genome Editing/Genome Engineering Market Value, By Country, 2018 – 2028
TABLE  Europe Genome Editing/Genome Engineering Market Value, By Segment1, 2018 – 2028
TABLE  Europe Genome Editing/Genome Engineering Market Value, By Segment2, 2018 – 2028
TABLE  Europe Genome Editing/Genome Engineering Market Value, By Country, 2018 – 2028
TABLE  Asia Pacific Genome Editing/Genome Engineering Market Value, By Segment1, 2018 – 2028
TABLE  Asia Pacific Genome Editing/Genome Engineering Market Value, By Segment2, 2018 – 2028
TABLE  Asia Pacific Genome Editing/Genome Engineering Market Value, By Country, 2018 – 2028
TABLE  Latin America Genome Editing/Genome Engineering Market Value, By Segment1, 2018 – 2028
TABLE  Latin America Genome Editing/Genome Engineering Market Value, By Segment2, 2018 – 2028
TABLE  Latin America Genome Editing/Genome Engineering Market Value, By Country, 2018 – 2028
TABLE  MEA Genome Editing/Genome Engineering Market Value, By Segment1, 2018 – 2028
TABLE  MEA Genome Editing/Genome Engineering Market Value, By Segment2, 2018 – 2028
TABLE  MEA Genome Editing/Genome Engineering Market Value, By Country, 2018 – 2028
TABLE  Agilent Technologies: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Beam Therapeutics: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Bluebird Bio Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Caribou Biosciences: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Cellectis S.A: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Creative Biogene: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Crispr Therapeutics Ag: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Editas Medicine: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Genscript: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Integrated Dna Technologies: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Intellia Therapeutics: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Lonza: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Merck Kgaa: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  New England Biolabs: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Origene Technologies: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Perkinelmer: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Precision Biosciences: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Recombinetics: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Regeneron Pharmaceuticals Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Sangamo Therapeutics: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Synthego Corporation: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Tecan Life Sciences: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Thermo Fisher Scientific: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Transposagen Biopharmaceuticals [Hera Biolabs]: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Vigene Biosciences: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
 

List of Figures

FIG.  Global Genome Editing/Genome Engineering Market: Research Methodology
FIG.  Top-Down and Bottom Up Approach
FIG.  Global Genome Editing/Genome Engineering Market, By Segment1, 2019 (US$ Mn)
FIG.  Global Genome Editing/Genome Engineering Market, By Segment2, 2019 (US$ Mn)
FIG.  Global Genome Editing/Genome Engineering Market, By Geography, 2019 (US$ Mn)
FIG.  Global Genome Editing/Genome Engineering Market Value and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG.  Attractive Investment Proposition
FIG.  Market Positioning of Key Genome Editing/Genome Engineering Providers, 2016
FIG.  Global Genome Editing/Genome Engineering Market Value Share, By Segment1, 2019 & 2028 (% Value)
FIG.  Global CRISPR Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global TALEN Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global ZFN Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Antisense Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Genome Editing/Genome Engineering Market Value Share, By Segment2, 2019 & 2028 (% Value)
FIG.  Global Cell Line Engineering Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Genetic Engineering Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Diagnostics Market Value, 2018 – 2028, (US$ Mn)
FIG.  U.S. Genome Editing/Genome Engineering Market Value, 2018 – 2028, (US$ Mn)
FIG.  Canada Genome Editing/Genome Engineering Market Value, 2018 – 2028, (US$ Mn)
FIG.  UK Genome Editing/Genome Engineering Market Value, 2018 – 2028, (US$ Mn)
FIG.  Germany Genome Editing/Genome Engineering Market Value, 2018 – 2028, (US$ Mn)
FIG.  France Genome Editing/Genome Engineering Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Europe Genome Editing/Genome Engineering Market Value, 2018 – 2028, (US$ Mn)
FIG.  China Genome Editing/Genome Engineering Market Value, 2018 – 2028, (US$ Mn)
FIG.  Japan Genome Editing/Genome Engineering Market Value, 2018 – 2028, (US$ Mn)
FIG.  India Genome Editing/Genome Engineering Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Asia Pacific Genome Editing/Genome Engineering Market Value, 2018 – 2028, (US$ Mn)
FIG.  Mexico Genome Editing/Genome Engineering Market Value, 2018 – 2028, (US$ Mn)
FIG.  Brazil Genome Editing/Genome Engineering Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Latin America Genome Editing/Genome Engineering Market Value, 2018 – 2028, (US$ Mn)
FIG.  GCC Countries Genome Editing/Genome Engineering Market Value, 2018 – 2028, (US$ Mn)
FIG.  South Africa Genome Editing/Genome Engineering Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of MEA Genome Editing/Genome Engineering Market Value, 2018 – 2028, (US$ Mn)